Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insight and human centricity.

Inizio Evoke

Biotechgate provides information and solutions for the life sciences industry, including databases for clinical trials and investor connections. The service offers access to business development and licensing information self-described as comprehensive.

Biotechgate

Business Consulting and Services

Inizio

Government Relations

Incisive Health

Advertising Services

Evolution Road

Inizio Evoke | 55,689 followers on LinkedIn. We are purpose-built to make health more human™. | Inizio Evoke is a global health marketing, communications, and transformation platform unlocking growth through data-driven insights and human centricity. We are purpose-built to make Health more human™.
 
With core expertise and specialty brands in Marketing, Comms, Transformation, Access, and Media, we serve as a premier partner for the world&#39;s most ambitious healthcare organizations.

Rosanne Johnson

Shannon Doherty

EVP Client Partner at Evoke Group

James Pietz

Charles Willson

Bias in healthcare isn’t just a challenge—it’s an opportunity for change. At Inizio Evoke, we’re reimagining the future of healthcare by addressing the hidden impact of bias on patient outcomes and business performance. Discover insights from our groundbreaking report in partnership with University College London (UCL). This global systematic review reveals how healthcare professional (HCP) bias can shape patient experiences and outcomes. Let's transform healthcare by turning awareness into action. Download the report to learn more: https://bit.ly/3Yh5Kuc #ReimagineHealth #HealthcareBias #HealthEquity #UCL #InizioEvokeEurope

In our dynamic industry, a one-size-fits-all approach simply doesn't work. That’s why we leverage intelligent paid media strategies to deliver tailored, impactful ads that go beyond just promotion—they provide real answers. Find out more: https://bit.ly/49obyEA #ReimagineHealth #HealthMoreHuman #InizioEvokeMedia #Media #PersonalizedHealth

Looking to elevate your omnichannel strategy? Learn more about how we harness data, journey mapping, and empathy to connect with patients and HCPs meaningfully and purposefully: https://bit.ly/48JseHa #ReimagineHealth #InizioEvokeTransformation #Omnichannel #OmnichannelStrategy #Innovation

📣 Big news! Stephanie DeViteri , President, North America, has been named to PRWeek 's 2024 Health Influencer 30 list! 📣 The esteemed list celebrates the most prominent players influencing healthcare and pharma public relations. This recognition reflects her purposeful and innovative leadership and the impact she's made within the health communications industry over the last two decades. Congratulations, Stephanie! Learn more about the honorees: https://bit.ly/3UP9yQx #InizioEvokeComms #HealthComms #PRWeek #PRWeekHealthInfluencer30 #Leadership

🗓️ Here is your daily reminder to register ( https://bit.ly/4f871cv ) for our next #BreaktheBubble event! 🇪🇺 Join us in Brussels (📍COMET Louise) for “All Cards on the Table – Health Policy from 2025” on 4 December. The world of EU health policy is buzzing with crucial developments: from Commissioner-designate for Health and Animal Welfare, Olivér Várhelyi's uphill confirmation battle, to the ripple effects of the US elections, and new files and debates on the horizon. There’s no doubt we’re at a pivotal moment. Take a front-row seat for an exclusive inside look at what’s to come for EU health policymaking in 2025 and beyond. A panel of top EU experts, moderated by our Senior Counsel, Hans Martens will take us deeper into these issues: 🗣️ Pernille Weiss-Ehler , Former MEP, Rapporteur for the General Pharmaceutical Legislation 🗣️ Anne Bucher , Bruegel Non-Resident Fellow and Former Director-General Health and Food Safety, DG SANTE 🗣️ Annabel Seebohm, LL.M. , Secretary General, COCIR And to bid farewell to 2024 a networking reception will follow the discussion. 🚨Seats are limited, so don’t miss the opportunity to grab yours! Information, programme and registration at this link ➵ https://bit.ly/4f871cv For more insights, reach out to Incisive Health’s Brussels team!

We harness insight, experience, and creativity, to advance health and wellbeing around the world. Curious to find out more? Learn how we’re helping break down barriers to better health: https://bit.ly/3U1js1T #HealthComms #SocialImpact #Biotech #ReimagineHealth #InizioEvokeComms

This week, we're excited to share how Inizio Evoke reimagines the future of healthcare alongside our colleagues at Inizio, Inizio Medical , Inizio Engage , and Inizio Advisory . Stay tuned as we share how our teams move the needle in the industry and unlock growth with data-driven insight and human centricity. #ReimagineHealth #InizioEvoke #HealthMoreHuman #Healthcare #Pharma

Looking to elevate your omnichannel strategy? Our experts have the tools to streamline the process. Our targeted use cases drive measurable outcomes, empowering clients to shift seamlessly from a multichannel approach to a fully integrated omnichannel approach. Get in touch to connect with our Transformation team: https://bit.ly/3TJixCV #OmnichannelStrategy #Omnichannel #HealthcareInnovation #InizioEvokeTransformation

What a night! Honored to be recognized for our work alongside our amazing client, Gedeon Richter, in two categories at last night's AMEC Awards 2024: 🏆 Gold Award - Best Use of Integrated Communication Measurement/Research 🏆 Silver Award - Most Effective Planning, Research, and Evaluation in Consumer Communications Big thanks to our talented teams involved in bringing this campaign to life. Congrats to all the finalists and winners! 👏 #AMECAwards #InizioEvoke #GedeonRichter #HealthcareCommunications #EndometriosisAwareness

Congratulations to Students 2 Science , a non-profit organization providing students in New Jersey with access to immersive STEM learning experiences to support future careers in biotechnology, engineering, healthcare, data science, and more. We’re proud to have partnered to announce the launch of the Apollo Technology Center, which will expand access to STEM education for all students in New Jersey. #STEMEducation #SocialImpact #HealthcareCommunications #InizioEvokeComms #Client #ProBono

Metric
Company Name	Inizio Evoke	Biotechgate
Symbol
MSH ID	COM:INIZIOEVOKE	COM:BIOTECHGATE
Market	PRIVATE	PRIVATE
Sector	Commercial & Professional Services	Commercial & Professional Services
Industry	Healthcare Marketing	Life Sciences
Country	US	CH
Stage
Employee Count
Website	inizioevoke.com	biotechgate.com
LinkedIn	inizioevoke	biotechgate
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	8.29K	2.80K
Web Traffic Growth	-0.34	2.27
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

INIZ

COM:INIZIOEVOKE

Inizio Evoke

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue